Hope Decederfelt
Overview
Explore the profile of Hope Decederfelt including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
306
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mwakingwe-Omari A, Healy S, Lane J, Cook D, Kalhori S, Wyatt C, et al.
Nature
. 2021 Jul;
595(7866):289-294.
PMID: 34194041
The global decline in malaria has stalled, emphasizing the need for vaccines that induce durable sterilizing immunity. Here we optimized regimens for chemoprophylaxis vaccination (CVac), for which aseptic, purified, cryopreserved,...
2.
Healy S, Anderson C, Swihart B, Mwakingwe A, Gabriel E, Decederfelt H, et al.
J Clin Invest
. 2021 Feb;
131(7).
PMID: 33561016
BACKGROUNDVaccines that block human-to-mosquito Plasmodium transmission are needed for malaria eradication, and clinical trials have targeted zygote antigen Pfs25 for decades. We reported that a Pfs25 protein-protein conjugate vaccine formulated...
3.
Ishizuka A, Lyke K, DeZure A, Berry A, Richie T, Mendoza F, et al.
Nat Med
. 2016 Jun;
22(6):692.
PMID: 27270781
No abstract available.
4.
Ishizuka A, Lyke K, DeZure A, Berry A, Richie T, Mendoza F, et al.
Nat Med
. 2016 May;
22(6):614-23.
PMID: 27158907
An attenuated Plasmodium falciparum (Pf) sporozoite (SPZ) vaccine, PfSPZ Vaccine, is highly protective against controlled human malaria infection (CHMI) 3 weeks after immunization, but the durability of protection is unknown....